| Members |
targetComponentId |
| Torulopsis candida |
Candida saitoana |
| Torulopsis glabrata |
Candida glabrata (organism) |
| Torulopsis pintolopesii |
Candida pintolopesii |
| Total biopterins |
Substance with biopterin structure (substance) |
| Total estimated daily energy intake |
Estimated quantity of intake of energy in 24 hours (observable entity) |
| Total excision of organ NOC |
Complete excision of organ (procedure) |
| Tourette's disorder |
Gilles de la Tourette's syndrome |
| toxémie gravidique |
Pre-eclampsia (disorder) |
| Toxic effect |
Poisoning |
| Toxic effect from eating shellfish |
Toxic effect from eating shellfish (disorder) |
| Toxic effect from noxious substance eaten as food, NEC |
Food poisoning |
| Toxic effect of chiefly nonmedicinal substance, NEC |
Toxic effect of chiefly nonmedicinal substance |
| Toxic effect of hydrocarbon gas, NEC |
Toxic effect of hydrocarbon gas |
| Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues |
Poisoning caused by substance with benzene structure (disorder) |
| Toxic effect of non-petroleum-based solvent |
Toxic effect of nonpetroleum-based solvent |
| effet toxique d'une substance nocive ingérée comme aliment |
Food poisoning |
| Toxic effect of other nonpetroleum-based solvent, NEC |
Toxic effect of nonpetroleum-based solvent |
| Toxic effect of tobacco and nicotine |
Nicotine poisoning |
| Toxic encephalopathy |
Toxic encephalopathy |
| Toxic liver disease with acute hepatitis |
Acute toxic hepatitis |
| Toxic liver disease with cholestasis |
Drug-induced intrahepatic cholestasis |
| Toxic porphyria, NEC |
Porphyria due to toxic effect of substance |
| Toxoplasma hepatitis |
Hepatitis caused by Toxoplasma gondii |
| Toxoplasmosis: [test] or [titre] |
Toxoplasmosis test |
| Toy in nose causing respiratory obstruction |
Obstruction of respiratory tract caused by toy in nose (disorder) |
| jouet ou gadget |
Toy |
| Tracheal endoscopy: [diagnostic rigid NOS] or [NEC] |
Endoscopy of trachea using rigid bronchoscope |
| Tracheostomy site |
Tracheostomy stoma |
| Tracheostomy, emergency procedure by cricothyroid membrane approach |
Emergency cricothyroidotomy |
| thérapie traditionnelle |
Complementary therapy |
| Tramadol hydrochloride 300mg m/r capsule |
Product containing only tramadol in oral dose form (medicinal product form) |
| Tramadol hydrochloride 300mg prolonged-release oral capsule |
Product containing only tramadol in oral dose form (medicinal product form) |
| Tramadol hydrochloride 50mg soluble tablet |
Product containing precisely tramadol hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Tramazoline hydrochloride+dexamethasone isonicotinate |
Product containing dexamethasone and tramazoline (medicinal product) |
| Trandolapril allergy |
Non-allergic hypersensitivity to trandolapril (finding) |
| Trandolapril+verapamil hydrochloride |
Product containing trandolapril and verapamil (medicinal product) |
| Trandolapril+verapamil hydrochloride 1mg/240mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 1mg/240mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 2mg/180mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 2mg/180mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 2mg/240mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 2mg/240mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 4mg/240mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 4mg/240mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Tranexamic acid 100mg/mL conventional release solution for injection 10mL vial |
Tranexamic acid 100 mg/mL solution for injection |
| Tranexamic acid 100mg/mL injection |
Tranexamic acid 100 mg/mL solution for injection |
| Tranexamic acid 100mg/mL intravenous solution 10mL vial |
Tranexamic acid 100 mg/mL solution for injection |
| Transacylase |
Transacylase |
| Transcarbamoylase |
Transcarbamoylase |
| Transcarboxylase |
Transcarboxylase |
| Transcortin |
Corticotropin binding globulin |
| Transdermal glyceryl trinitrate allergy |
Allergy to nitroglycerin |
| Transfer of forearm tendon or muscle |
Transposition procedure |
| Transfer of pedicle flap graft |
Reconstruction using pedicle skin flap (procedure) |
| Transformiminase |
Transformiminase |
| Transformylase |
Transhydroxymethylase |
| Transfusion reaction NOS |
Blood transfusion reaction |
| Transfusion reaction caused by specific isoantibody |
Blood transfusion reaction |
| Transfusion reaction due to isoantibody |
Blood transfusion reaction |
| Transhepatic |
Transhepatic approach |
| Transhydroxymethylase |
Transhydroxymethylase |
| Transient |
Transitory |
| Transient hematological disorder, NEC |
Transient neonatal hematological disorder |
| Transient ischemic attack clinical management plan |
Transient ischemic attack clinical management plan (record artifact) |
| Transient situational disturbance |
Adjustment disorder |
| Transorbital |
Transorbital approach |
| Transplant of lymphatic structure |
Transplantation of lymphatic structure |
| Transrectal biopsy of prostate |
Transrectal needle biopsy of prostate (procedure) |
| Transsexualism |
Transsexual (finding) |
| Transsexualism NOS |
Transsexual (finding) |
| Transsexualism, previously asexual |
Previously asexual transsexual (finding) |
| Transsexualism, previously heterosexual |
Previously heterosexual transsexual (finding) |
| Transsexualism, previously homosexual |
Previously homosexual transsexual (finding) |
| Transsexuality with asexual history |
Previously asexual transsexual (finding) |
| Transsexuality with heterosexual history |
Previously heterosexual transsexual (finding) |
| Transsexuality with homosexual history |
Previously homosexual transsexual (finding) |
| Transsexuality with unspecified sexual history |
Transsexual (finding) |
| Transthoracic echocardiography |
Transthoracic echocardiography (procedure) |
| prostatectomie transurétrale à l'emporte-pièce |
Transurethral prostatectomy |
| Transverse presentation |
Transverse lie |
| Transvestism |
Cross-dressing |
| Trastuzumab |
Trastuzumab (substance) |
| Traumatic perforation |
Perforating wound |
| Traumatic skin changes |
Injury to skin caused by trauma |
| Travel vaccination given |
Travel vaccination given (situation) |
| Treatment of glaucoma |
Medicinal product acting as antiglaucoma agent (product) |
| Tremor due to drug withdrawal |
Tremor due to substance withdrawal (finding) |
| Treponema pallidium |
Treponema pallidum |
| Tretinoin 0.05% liquid |
Tretinoin 500 microgram/mL cutaneous solution |
| Trial of micturition without catheter |
Trial without catheter |
| Triamcinolone acetonide 100mcg/spray |
Product containing only triamcinolone (medicinal product) |
| Triamcinolone acetonide 3mg injection suspension ampule 1mL |
Triamcinolone acetonide 3 mg/mL suspension for injection |
| Triamcinolone acetonide 40mg injection suspension ampule |
Triamcinolone only product in parenteral dose form |
| Triamcinolone acetonide 40mg/mL suspension |
Product containing only triamcinolone (medicinal product) |
| Triamcinolone diacetate 25mg/mL injection suspension ampule |
Triamcinolone diacetate 25 mg/mL suspension for injection |
| Triamcinolone diacetate 40mg/mL injection suspension ampule |
Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Triazole derivative |
Substance with triazole structure (substance) |
| Tribavirin 6g inhalation (pdr for recon) |
Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| érythrodermie ichthyosiforme congénitale récessive |
Trichothiodystrophy (disorder) |
| Trichoglossus haematodos forsteni |
Trichoglossus forsteni (organism) |
| Trichomoniasis of other sites |
Infection by Trichomonas |
FHIR